NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
06/15/2023
Back to search
Official data from USPTO
METHERGINE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
06/15/2023
Trademark type
Word
Nice classes
5, 6
Filing date
11/18/1942
Registration date
04/06/1943
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/15/2023
Last transaction
06/15/2023
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
10/24/1942
First use in commerce
10/24/1942
Drawing code
1
Owner type
03
Owner location
BASEL, CH
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
NOVARTIS AG
N. C. (pessoa física)
S. C. (pessoa física)
Sandoz, Inc.
Sandoz Chemical Works, Inc.
Representatives
Maury M. Tepper, III TEPPER & EYSTER, PLLC
Technical classification
Nice Classes
Class 5Class 6
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
No specification.
Class 6
Medicinal Preparation for Use in the Prevention and Treatment of Uterine Hemorrhages and Other Recognized Indications for Ergonovine Therapy
Publications
History of USPTO decisions and trademark events.
28 publications found
RNL5
REGISTERED AND RENEWED (FIFTH RENEWAL - 10 YRS)
06/15/2023
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
06/15/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/15/2023
E89R
TEAS SECTION 8 & 9 RECEIVED
11/18/2022
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
04/06/2022
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
03/01/2013
RNL4
REGISTERED AND RENEWED (FOURTH RENEWAL - 10 YRS)
03/01/2013
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
03/01/2013
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/01/2013
E89R
TEAS SECTION 8 & 9 RECEIVED
02/18/2013
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
06/27/2012
CORV
REVIEW OF CORRESPONDENCE COMPLETE
08/10/2009
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/17/2009
CFIT
CASE FILE IN TICRS
10/01/2008
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/19/2004
PAPER RECEIVED
12/06/2004
RNL3
REGISTERED AND RENEWED (THIRD RENEWAL - 10 YRS)
05/31/2003
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
05/31/2003
89AF
REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
03/26/2003
E89R
TEAS SECTION 8 & 9 RECEIVED
03/26/2003
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
06/21/1990
RRPR
RESPONSE RECEIVED TO POST REG. ACTION
05/29/1990
PR23
POST REGISTRATION ACTION MAILED - SEC. 8 & 15
12/27/1989
815F
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
03/30/1989
REN2
REGISTERED AND RENEWED (SECOND RENEWAL - 20 YRS)
05/31/1983
REN2
REGISTERED AND RENEWED (SECOND RENEWAL - 20 YRS)
04/06/1983
P12C
PUBLISHED SECTION 12(C)
04/05/1983
Continuous trademark protection
Get notified about every new filing that threatens METHERGINE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.